Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
N Engl J Med 2014 Aug 28
Two clinical phenotypes in polycythemia vera.
Related Questions
Under which circumstances would you prefer ropeginterferon over hydroxyurea for patients with Polycythemia Vera?
Ropeginterferon is now a preferred therapy for Polycythemia Vera (PV) as per a recent update to the NCCN guidelines.
19824
×
To continue please login or register
Register
or
Sign in